---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006036"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T22:58:40.097014+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Anebulo sets 2025 annual meeting for April 4; stockholder proposals due Feb 22

## Summary
- Annual Meeting scheduled for April 4, 2025; location to be in proxy materials.
- Stockholder proposals for inclusion in proxy must be received by February 22, 2025.
- Director nominations and other proposals not in proxy also due by February 22, 2025.
- Universal proxy rule compliance deadline is February 22, 2025 (10 days after 8-K filing).
- Meeting date more than 30 days after prior year's anniversary, resetting prior deadlines.

## SEC filing metadata
- accession: 0001493152-25-006036
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315225006036/0001493152-25-006036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315225006036/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006036
- JSON: https://secwatch.observer/filing/0001493152-25-006036.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.